Should we discard vinorelbine plus cisplatin from the first-line therapy of advanced non-small-cell lung cancer?

被引：2
作者：
Dediu, M [1 ]
机构：
[1] Inst Oncol Bucharest, Bucharest, Romania
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 07期
关键词：
D O I：
10.1200/JCO.2004.99.228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1345 / 1347
页数：3
相关论文
共 11 条
  • [1] Health-related quality of life in non-small-cell lung cancer: Methodologic issues in randomized controlled trials
    Bottomley, A
    Efficace, F
    Thomas, R
    Vanvoorden, V
    Ahmedzai, SH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 2982 - 2992
  • [2] Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group
    Fossella, F
    Pereira, JR
    von Pawel, J
    Pluzanska, A
    Gorbounova, V
    Kaukel, E
    Mattson, KV
    Ramlau, R
    Szczesna, A
    Fidias, P
    Millward, M
    Belani, CP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3016 - 3024
  • [3] GEBBIA V, 2003, LUNG CANCER S4, V41, pS63
  • [4] Giaccone G, 2001, EUR J CANCER, V37, pS99
  • [5] GRALLA RJ, 1997, P AN M AM SOC CLIN, V16, pA420
  • [6] Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66
  • [7] Quality trials and quality of life in non-small-cell lung cancer
    Harper, P
    Plunkett, T
    Khayat, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3007 - 3008
  • [8] Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial
    Kelly, K
    Crowley, J
    Bunn, PA
    Presant, CA
    Grevstad, PK
    Mainpour, CM
    Ramsey, SD
    Wozniak, AJ
    Weiss, GR
    Moore, DF
    Israel, VK
    Livingston, RB
    Gandara, DR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) : 3210 - 3218
  • [9] PARRA HJS, 2000, P AN M AM SOC CLIN, V19, pA546
  • [10] RAFTOPOULOS H, 2003, LUNG CANCER, V41, pS68
12